Show simple item record

The cost–effectiveness of rivaroxaban compared to enoxaparin plus adjusted-dose warfarin for the treatment of deep venous thrombosis (DVT) in Turkey.

dc.contributor.authorİNCE, Fatma Birsen
dc.date.accessioned2021-03-06T11:02:18Z
dc.date.available2021-03-06T11:02:18Z
dc.identifier.citationİNCE F. B. , "The cost–effectiveness of rivaroxaban compared to enoxaparin plus adjusted-dose warfarin for the treatment of deep venous thrombosis (DVT) in Turkey.", ISPOR 18th Annual International Meeting, New Orleans, Amerika Birleşik Devletleri, 18 - 22 Mayıs 2013, ss.287-288
dc.identifier.othervv_1032021
dc.identifier.otherav_ed314a0a-36b9-433d-acbf-afc3e6e67193
dc.identifier.urihttp://hdl.handle.net/20.500.12627/155706
dc.language.isoeng
dc.subjectÇOK DİSİPLİNLİ BİLİMLER
dc.subjectTemel Bilimler
dc.subjectDoğa Bilimleri Genel
dc.subjectTemel Bilimler (SCI)
dc.titleThe cost–effectiveness of rivaroxaban compared to enoxaparin plus adjusted-dose warfarin for the treatment of deep venous thrombosis (DVT) in Turkey.
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.contributor.firstauthorID318646


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record